$3.680
-0.493 (-13.41%)收盤時
GCTK 獲利能力與利潤率
Evaluating the bottom line, GlucoTrack Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -527.20%, provide a clear picture of how effectively GCTK converts its operational activities into shareholder value.
GCTK 同業比較
In the context of the broader market, GCTK competes directly with industry leaders such as BIAF and NUWE. With a market capitalization of $2.98M, it holds a significant position in the sector. When comparing efficiency, GCTK's gross margin of N/A stands against BIAF's 23.91% and NUWE's 76.08%. Such benchmarking helps identify whether GlucoTrack Inc is trading at a premium or discount relative to its financial performance.
GlucoTrack Inc 財務表現
GlucoTrack has reported continuous net losses, with the latest net income showing a loss of $4,334,000 in Q1 2026. The company's current ratio is low at 0.85, indicating potential liquidity issues.
Financials
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。